Can a shorter TB regimen transform child care?
NCT ID NCT07747792
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study looks at how a shorter tuberculosis (TB) treatment regimen works for children and adolescents with non-severe TB in Zambia. It involves children, caregivers, health workers, and policymakers to understand how well the regimen is accepted, followed, and feasible in real-world settings. The study also tracks treatment outcomes, including success rates and relapse after one year, to see if the shorter regimen is effective in practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A shorter tuberculosis treatment regimen
- What this could lead to
- If successful, this could support wider use of shorter TB treatment for children, making care easier and more effective.
- What could go wrong
- This is an evaluation study, not a randomized trial, so results may be influenced by real-world conditions. The shorter regimen may not work as well in all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS (TB) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CIDRZ
Lusaka, Lusaka Province, 10101, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app lift the shame of TB?
- A mobile x-ray van with AI could spot TB before it spreads
- AI-Powered skin patch could bring TB prevention to People's doorsteps
- Can exercise and breathing training repair lungs damaged by TB?
- Community-Driven TB screening aims to reach vulnerable immigrants
- Smartphone Check-Ins could boost TB treatment success